Carl‐gerhard Gottfries

Carl‐gerhard Gottfries's AcademicInfluence.com Rankings

Philosophy

#8017

World Rank

#11317

Historical Rank

Logic

#5056

World Rank

#6415

Historical Rank

philosophy Degrees

Carl‐gerhard Gottfries

Biology

#10813

World Rank

#14170

Historical Rank

Neuroscience

#1705

World Rank

#1759

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Carl‐gerhard Gottfries Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Carl‐gerhard Gottfries's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer Type (1979) (451)
The Clinical Efficacy of Citalopram in Treatment of Emotional Disturbances in Dementia Disorders a Nordic Multicentre Study (1990) (390)
Membrane Lipids, Selectively Diminished in Alzheimer Brains, Suggest Synapse Loss as a Primary Event in Early‐Onset Form (Type I) and Demyelination in Late‐Onset Form (Type II) (1994) (323)
Biochemical changes in Dementia disorders of Alzheimer type (AD/SDAT) (1983) (305)
A new rating scale for dementia syndromes. (1982) (272)
A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia (1992) (259)
Identification of Cognitive Impairment in the Elderly: Homocysteine Is an Early Marker (1998) (257)
Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. (1980) (252)
DETERMINATION OF MONOAMINE AND MONOAMINE METABOLITES IN THE HUMAN BRAIN: POST MORTEM STUDIES IN A GROUP OF SUICIDES AND IN A CONTROL GROUP (1976) (215)
Treatment of Alzheimer’s Disease with Clioquinol (2001) (210)
Late life depression (2009) (192)
Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism. (1980) (163)
Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex. (1971) (162)
The neurochemistry of vascular dementia. (1994) (152)
A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale). (2002) (149)
Brain and brain monoamine oxidase in aging and in dementia of Alzheimer's type (1986) (128)
The Investigation of Homovanillic Acid in the Human Brain and its Correlation to Senile Dementia (1969) (125)
Changes in uptake of vitamin B12 and trace metals in brains of mice treated with clioquinol (2000) (122)
Superoxide dismutase isoenzymes in normal brains and in brains from patients with dementia of Alzheimer type (1985) (120)
A new rating scale for dementia syndromes. (1982) (105)
Stepwise Comparative Status Analysis (STEP): A Tool for Identification of Regional Brain Syndromes in Dementia (1996) (101)
Low platelet monoamine oxidase activity in human alcoholics. (1977) (99)
The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains (1999) (99)
Vitamin B12-B6-Folate Treatment Improves Blood-Brain Barrier Function in Patients with Hyperhomocysteinaemia and Mild Cognitive Impairment (2003) (92)
Monoamine oxidase B in brains from patients with Alzheimer's disease: A biochemical and autoradiographical study (1991) (91)
Mitochondrial Function is Differentially Altered in the Basal Ganglia of Chronic Schizophrenics (1999) (88)
Membrane Components Separate Early-Onset Alzheimer's Disease From Senile Dementia of the Alzheimer Type (1996) (83)
Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model (2018) (83)
SOEME OBSERVATIONS ON ADRENERGIC CONNECTIONS BETWEEN MESENCEPHALON AND CEREBRAL HEMISPHERES. (2009) (81)
Is there a difference between elderly and younger patients with regard to the symptomatology and aetiology of depression? (1998) (80)
Protein Analysis in Cerebrospinal Fluid (1993) (80)
The Role of the Polymorphic Genes Apolipoprotein E and Methylene- tetrahydrofolate Reductase in the Development of Dementia of the Alzheimer Type (1999) (77)
The Gottfries-Bråne-Steen Scale: Validity, Reliability and Application in Anti-Dementia Drug Trials (2000) (77)
Transmitter deficits in Alzheimer's disease (1985) (71)
Post-mortem distribution of dopamine and homo-vanillic acid in human brain, variations related to age, and a review of the literature (2005) (70)
Early diagnosis of cognitive impairment in the elderly with the focus on Alzheimer's disease (1998) (70)
THE EFFECT OF LITHIUM CARBONATE IN COMBINATION WITH TRICYCLIC ANTIDEPRESSANTS IN ENDOGENOUS DEPRESSION: A double‐blind, multicenter trial (1974) (66)
Platelet monoamine oxidase activity in mental disorders: 2. Affective psychoses and suicidal behavior. (1980) (66)
Brain gamma-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease (1992) (65)
Brain and platelet monoamine oxidase in mental disorders 1. Schizophrenics and cycloid psychotics. (1980) (65)
Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease (1992) (61)
Synaptic degeneration in thalamus in schizophrenia (1996) (60)
Homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid related to rated mental and motor impairment in senile and presenile dementia. (1970) (59)
Putamen Mitochondrial Energy Metabolism Is Highly Correlated to Emotional and Intellectual Impairment in Schizophrenics (2000) (52)
VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase, in brain tissue afflicted by alzheimer's disease/senile dementia of the Alzheimer type (1988) (51)
Intracerebroventricular administration of GM1 ganglioside to presenile Alzheimer patients. (1997) (49)
Monoamine oxidase in platelets and brains of non-psychiatric and non-neurological geriatric patients. (1979) (48)
Homocysteinemia and schizophrenia as a case of methylation deficiency (2005) (48)
Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia (2002) (48)
Presence of parieto‐temporal symptomatology distinguishes early and late onset Alzheimer's disease (1991) (47)
Disturbance of the 5-hydroxytryptamine metabolism in brains from patients with Alzheimer's dementia. (1990) (46)
Treatment with staphylococcus toxoid in fibromyalgia/chronic fatigue syndrome—a randomised controlled trial (2002) (44)
Treatment of depression in elderly patients with and without dementia disorders. (1992) (43)
Subcortical symptoms predominate in vascular dementia (1991) (43)
Homozygous thermolabile methylenetetrahydrofolate reductase in schizophrenia-like psychosis (2005) (43)
Disturbances of one-carbon metabolism in neuropsychiatric disorders: A review (1997) (43)
Neurochemical Aspects of Dementia Disorders (1990) (42)
Confusional State Evaluation (CSE): An instrument for measuring severity of delirium in the elderly (1997) (42)
Reduction of the small synaptic vesicle protein synaptophysin but not the large dense core chromogranins in the left thalamus of subjects with schizophrenia (1999) (40)
Epitopes of Microbial and Human Heat Shock Protein 60 and Their Recognition in Myalgic Encephalomyelitis (2013) (39)
One-Carbon Metabolism and Other Biochemical Correlates of Cognitive Impairment as Visualized by Principal Component Analysis (2001) (39)
Vitamin B12 Analogues, Homocysteine, Methylmalonic Acid, and Transcobalamins in the Study of Vitamin B12 Deficiency in Primary Degenerative Dementia (1990) (39)
ACID MONOAMINE METABOLITES IN CEREBROSPINAL FLUID FROM PATIENTS WITH PRESENILE DEMENTIA (ALZHEIMER'S DISEASE) (1973) (38)
Cerebrospinal Fluid pH and Monoamine and Glucolytic Metabolites in Alzheimer's Disease (1974) (37)
Alzheimer's disease and senile dementia: Biochemical characteristics and aspects of treatment (2004) (37)
Slowed synthesis of DNA and methionine is a pathogenetic mechanism common to dementia in Down's syndrome, AIDS and Alzheimer's disease? (1992) (36)
Multiple biochemical deficits in both gray and white matter of Alzheimer brains (1986) (36)
Reduction of chromogranin A and B but not C in the cerebrospinal fluid in subjects with schizophrenia (1999) (36)
Distribution of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in human brain in relation to age, drug influence, agonal status and circadian variation (2005) (36)
Neurophysiological measures related to levels of 5-hydroxyindoleacetic acid, homovanillic acid and tryptophan in cerebrospinal fluid of psychiatric patients. (1976) (35)
Advanced catecholaminergic disturbances in the brain in a case of Wilson's disease (1982) (35)
Formulas for the quantitation of intrathecal IgG production Their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis (1994) (34)
Alzheimer's disease. A critical review. (1988) (34)
The growth-associated protein GAP-43 is increased in the hippocampus and in the gyrus cinguli in schizophrenia (1999) (33)
BRAIN-LEVELS OF MONOAMINE OXIDASE IN DEPRESSION (1974) (32)
CSF-methionine is elevated in psychotic patients (2004) (31)
Transcobalamin Polymorphism and Serum Holo-Transcobalamin in Relation to Alzheimer’s Disease (2004) (31)
The metabolism of some neurotransmitters in ageing and dementia disorders. (1982) (31)
Neuropeptides and Alzheimer's disease (1995) (30)
Response to Vitamin B12 and Folic Acid in Myalgic Encephalomyelitis and Fibromyalgia (2015) (29)
Effect of Citalopram, a Selective 5‐HT Reuptake Blocker, in Emotionally Disturbed Patients with Dementia a (1991) (29)
Influence of depression and antidepressants on weight (1981) (28)
GRAVE LITHIUM INTOXICATION WITH FATAL OUTCOME (1974) (27)
Hypothalamic monoamines and neuropeptides in dementia (1991) (26)
Nickel Allergy Is Found in a Majority of Women with Chronic Fatigue Syndrome and Muscle Pain- And May Be Triggered by Cigarette Smoke and Dietary Nickel Intake (2001) (26)
Long-Term Treatment of Elderly Individuals With Emotional Disturbances: An Open Study With Citalopram (1996) (25)
Biochemistry of dementia and normal ageing (1980) (24)
Heterogeneity of the Course of Alzheimer's Disease: A Differentiation of Subgroups (1991) (23)
Monoamine oxidase activity and serotoninergic turnover in human brain (1978) (23)
Intra‐Blood-Brain‐Barrier Synthesis of Immunoglobulins in Patients with Dementia of the Alzheimer Type (1990) (21)
Brain Monoamines, Monoamine Metabolites and Enzymes in Physiological Ageing and Senile Dementia (1978) (21)
Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients – A validation study in plasma and cerebrospinal fluid from two Swedish cohorts (2020) (21)
Increased proteolytic activity in lymphocytes from patients with early onset Alzheimer's disease (1995) (21)
Activities of daily living ratings of elderly people using Katz' ADL Index and the GBS-M scale. (1995) (21)
Treatment of Depression in Elderly Patients With and Without Dementia Disorders (1992) (20)
Vitamin B12-induced reduction of platelet monoamine oxidase activity in patients with dementia and pernicious anaemia (1991) (20)
Scandinavian experience with citalopram in the elderly (1996) (20)
Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients (2019) (19)
Erythrocyte and brain methionine adenosyltransferase activities in patients with schizophrenia (1998) (19)
Visualization of brain monoamine oxidase B (MAO-B) in dementia of Alzheimer's type by means of large cryosection autoradiography: a pilot study. (1990) (19)
Neurotransmitters in the brain. (1989) (18)
Recognition and management of depression in the elderly (1997) (18)
Cholecystokinin peptides and receptor binding in Alzheimer's disease (2005) (17)
Changes in dopamine receptor sensitivity in humans after heavy alcohol intake (2004) (17)
Six-month open trial with Zimelidine in alcohol-dependent patients: reduction in days of alcohol intake. (1994) (15)
Hypothalamic dysfunction in dementia. (1994) (15)
Evidence for biochemical heterogeneity in schizophrenia: a multivariate study of monoaminergic indices in human post-mortal brain tissue (2005) (15)
Alzheimer's disease : clinical and treatment perspectives (1995) (14)
Murine Gammaretrovirus Group G3 Was Not Found in Swedish Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia (2011) (14)
Quality of life and standard of living in a randomly selected group of psychiatrically disabled people in Sweden 2 years after a psychiatry reform (2002) (14)
Immune Modulation with a Staphylococcal Preparation in Fibromyalgia/Chronic Fatigue Syndrome: Relation Between Antibody Levels and Clinical Improvement (2004) (14)
Protein analysis in cerebrospinal fluid. III. Relation to blood-cerebrospinal fluid barrier function for formulas for quantitative determination of intrathecal IgG production. (1993) (14)
Neurochemical Changes in White Matter of Patients with Alzheimer’s Disease (1987) (14)
Effect of iproniazid on monoamines and monoamine oxidase in human brain (1962) (14)
Review of treatment strategies (1992) (13)
HUMAN BRAIN LEVELS OF MONOAMINES AND THEIR METABOLITES. POSTMORTEM INVESTIGATIONS (1980) (13)
Pharmacology of mental aging and dementia disorders. (1987) (13)
Flupenthixol and Trifluoperazine: A Double-blind Investigation in the Treatment of Schizophrenics (1971) (13)
Recommendations for Clinical Drug Trials in Dementia (1990) (12)
No Evidence for Xenotropic Murine Leukemia-Related Virus Infection in Sweden Using Internally Controlled Multiepitope Suspension Array Serology (2012) (12)
Increased monoamine oxidase activity and vitamin B-12 deficiency in dementia disorders (1990) (12)
Influence of vitamin B12 on brain methionine adenosyltransferase activity in senile dementia of the Alzheimer's type (2005) (12)
Pharmacological treatment strategies in Alzheimer type dementia (1990) (11)
[Clinical experiences with flupenthixol in psychiatric patients]. (1967) (11)
[A quality assurance instrument at ambulatory health centers. A scale for identification of depression among the elderly]. (1997) (11)
Objective Recording of Arm and Leg Activity in Normal and Clinical Samples (1966) (11)
FLUPENTHIXOL DECANOATE ‐CONTROLLED INVESTIGATION CONCERNING DOSAGE (1974) (11)
A randomised controlled trial of the monoaminergic stabiliser (−)-OSU6162 in treatment of myalgic encephalomyelitis/chronic fatigue syndrome (2017) (11)
Normal aging, Alzheimer's disease, and senile dementia, aspects on etiology, pathogenesis, diagnosis, and treatment : proceedings of two symposia held at the Collegium International Neuro-psychopharmacologicum 14th Congress, June 22 and 23, 1984, Florence, Italy (1985) (11)
Biogenic Amines and Related Enzymes in Normal Aging, Senile Dementia and Chronic Alcoholism (1981) (11)
The GBS scale: A New Rating Scale for Dementia Syndromes (1986) (10)
Pharmacological Treatment of Sleep Disorders (1979) (10)
Monoamines and their metabolites and monoamine oxidase activity related to age and to some dementia disorders (1979) (10)
Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Not Due to Anti-mitochondrial Antibodies (2020) (10)
Reductions in Membrane Proteins and Lipids in Basal Ganglia of Classic Alzheimer Disease Patients (1996) (10)
Clinical classification of dementias. (1995) (9)
The Closure of a Major Psychiatric Hospital: Can Psychiatric Patients in Long-Term Care Be Integrated Into Existing Nursing Homes? (1991) (9)
Alzheimer's disease—one, two, or several? (1989) (9)
Pharmacokinetic studies on flupenthixol and flupenthixol decanoate in man using tritium labelled compounds (2004) (9)
Increased Proteolytic Activity in Erythrocytes from Patients with Alzheimer's Disease (1992) (8)
Treatment of depression in the elderly. General clinical considerations (1981) (8)
Absence of basal ganglia amino acid neuron deficits in schizophrenia in three collections of brains (1998) (8)
Neurochemistry and Neurotransmitters (1997) (8)
METHODOLOGICAL ASPECTS OF POST-MORTEM INVESTIGATIONS OF HUMAN BRAIN -WITH SPECIAL REFERENCE TO MONOAMINES AND RELATED ENZYMES (1978) (8)
The activity of monoamine oxidase -A and -B in brains from chronic alcoholics (2005) (8)
The clonidine test in patients with dementia disorders: Relation to clinical status and cerebrospinal fluid metabolite levels (1988) (8)
Clinical and Neurochemical Aspects of Diseases with Cognitive Impairment (1992) (7)
The closure of a major psychiatric hospital (1991) (7)
Disturbance of the 5-hydroxytryptamine metabolism in ageing and in Alzheimer's and vascular dementias (1991) (6)
Monoamines and myelin components in aging and dementia disorders. (1986) (6)
Neurochemical Changes in Brains from Patients with Vascular Dementia (1991) (6)
Late effects on rabbit brain morphology and monoamine metabolites produced by 60C0-irradiation. (1976) (6)
Brain monoamines and their metabolites in dementia. (1990) (6)
Cerebrospinal Fluid Cytology in Alzheimer's Disease (1991) (5)
Short-term nursing staff reactions to the closure of a major psychiatric hospital (1989) (5)
The closure of a major psychiatric hospital. Characterization of the long-term population over one year at an early stage of deinstitutionalization. (1991) (5)
Open study with (−)‐OSU6162 in multiple sclerosis‐related fatigue (2018) (5)
Investigation of Intrathecal Synthesis of Immunoglobulin G in Primary Degenerative Dementia (Alzheimer's Disease) (1991) (5)
Man's emotional capacity--an unexplored and unexploited possibility. (1994) (5)
Future prospects of research on central cholinergic mechanisms. (1990) (4)
Subject Index Vol. 1, 1990 (1990) (4)
Simple steps to diagnosis at primary care centres (1998) (4)
The diagnosis of Alzheimer's disease (1993) (4)
Visual averaged evoked responses in psychiatric patients. Relationship to levels of 5-hydroxy-indoleacetic acid, homovanilic acid and tryptophan in cerebrospinal fluid. (1979) (4)
The closure of a mental hospital in Sweden: Characteristics of patients in long-term care facing relocation into the community (2005) (4)
[Clinical trial of flupenthixol decanoate as a depot neuroleptic]. (1971) (4)
Neurotransmitters in the brains of patients with dementia disorders. (1985) (4)
[Depression and anxiety in the elderly still underdiagnosed. SSRI preparations in conjunction with psychotherapy provide effective treatment]. (2001) (3)
Quantitative Utilization of Psychiatric Care Over 5 Years by Schizophrenic Patients Discharged from a Major Psychiatric Hospital (1996) (3)
[Dementia conditions during aging. Several risk factors in Alzheimer disease]. (1995) (3)
MONOAMINE LEVELS AND CHOLINE ACETYLASE ACTIVITY IN BRAIN AND EFFECT OF RESERPINE AND DIHYDROXYPHENYLALANINE AFTER CEREBRAL LESIONS. (1963) (3)
Dementia: classification and aspects of treatment. (1988) (3)
Vascular Dementia (Hardcover Reprint): Etiological, Pathogenetic, Clinical and Treatment Aspects (1994) (3)
Diagnosis and Treatment of Senile Dementia: Early Diagnosis and Differential Diagnosis (1989) (3)
Classifying Organic Mental Disorders and Dementia—A Review of Historical Perspectives (1991) (3)
DEFINITION OF NORMAL AGING AND DEMENTIA (1984) (3)
Drug treatment of cognitive impairment and emotional disturbances in the elderly (1993) (3)
Vascular Dementia : etiological, pathogenetic, clinical and treatment aspects (1994) (2)
Depression and Alzheimer’s Disease (1997) (2)
The biochemical aspects and CSF markers in Alzheimer's disease (1993) (2)
Increased affinity of choline acetyltransferase for choline in Alzheimer's disease: a steady-state kinetic study (1987) (2)
Analytical Problems in Post-mortem Brain Studies (1981) (2)
PERIVENTRICULAR WHITE MATTER LOW ATTENUATION ON CT IN DEMENTIA OF THE ALZHEIMER TYPE AND VASCULAR DEMENTIA (1988) (2)
[Immunologic disturbances can explain chronic fatigue syndrome. Biological findings point towards somatogenesis]. (2009) (2)
Rationale for the Use of Therapeutic Agents in Affective Disorders (AD) and Senile Dementia of the Alzheimer Type (SDAT) (1985) (2)
[Comparative studies on flupenthixol and flupenthixol decanoate in amimal and man]. (1973) (2)
Cathecholamines in the human brain and ageing. (1977) (2)
Pharmacological treatment strategies in dementia disorders. (1989) (2)
Relationship between Growth Hormone Responses to Apomorphine and CSF Homovanillic Acid Levels in Dementia of the Alzheimer Type (1992) (2)
[The use of tranquilizers]. (1973) (2)
The Scandinavian Association of Psychopharmacology - 25 years (1984) (2)
TREATMENT WITH MONOAMINERIC DRUGS IN AD AND SD (1984) (2)
Long-Term Treatment with a Staphylococcus Toxoid Vaccine in Patients with Fibromyalgia and Chronic Fatigue Syndrome (2006) (2)
Pharmacokinetics of zimeldine in male alcoholics. (2009) (2)
Early Identification of Cognitive Impairment in the Elderly (1998) (1)
Controlled Investigation with Cinnarizin in the Treatment of Dementia Conditions in Old Age (1970) (1)
Neurotransmitter and Dementia (1990) (1)
Clinical Management in Europe of Patients with Dementia (1986) (1)
Differential diagnosis of early Alzheimer’s disease (1990) (1)
Recent advances in the treatment of depression. Proceedings of an international symposium, Corfu, Greece, April 16--18, 1980. (1981) (1)
[Vitamin B 12 deficiency--even a neuropsychiatric problem]. (1992) (1)
CSF AMINE METABOLITES IN VARIOUS NEUROLOGICAL AND PSYCHIATRIC DISEASES (1976) (1)
Dementia and neuropeptides (1991) (1)
The Occurrence of Homovanillic Acid in Human Brain (2009) (1)
Alzheimer Type Dementia — One or Several Disorders? (1990) (1)
Gangliosides and Alzheimer’s Disease (1995) (1)
Human brain levels of monoamines and their metabolites. Postmortem investigations. (1980) (1)
[Sick listing--"disaster" or incompetence in statistics and diagnostics?]. (2003) (1)
How do drugs influence the metabolism of neurotransmitters (1993) (1)
P-15-23 Disturbances of one-carbon metabolism in schizophrenia (1996) (1)
L-18 Depression, antidepressant drug treatment and cognitive impairment in old age (1996) (1)
80-5 Recognition and management of depression in the elderly (1997) (1)
Flupentixol and flupentixol decanoate, with special reference to their antipsychotic effect. (1974) (1)
[Experiments with regional-decentralised psychiatric outpatient treatment in Umeå hospital district]. (1975) (1)
Treatment with Serotonergic Drugs of Emotional Disturbances in Patients with Dementia Disorders (1994) (1)
A pilot trial of sectorized and decentralized psychiatric care in northern Sweden (1976) (1)
BRAIN AND PLATELET MONOAMINE OXIDASE (MAO) ACTIVITIES IN RELATION TO ETHANOL ABUSE (1979) (1)
Monoamine oxidase activity in gamma-irradiated rat brains. (1977) (1)
Overview of Age-Related Dementias (1993) (0)
[Psychiatry today: biological aspects]. (1972) (0)
[Drug therapy of migraine. A communication occasioned by information in the daily press]. (1963) (0)
Phyloscan with G20c homologs of 25 bacterial and protozoal HSP60s for IgG (A) and IgM (B) binding. (2013) (0)
Open‐label study with the monoamine stabilizer (‐)‐OSU6162 in myalgic encephalomyelitis/chronic fatigue syndrome (2021) (0)
Depression in the elderly: Treatment strategies (1993) (0)
DISCUSSION – SESSION 6 (1981) (0)
[Two cases of jaundice following marsilid treatment]. (1959) (0)
Alzheimer's disease. Review of treatment strategies. (1992) (0)
Subject Index Vol. 12, 2001 (2001) (0)
Methionine adenosyltransferase (MAT) activities in the brain and in erythrocytes of patients with dementia and schizophrenia (1995) (0)
[Disturbances of monoamine metabolism in organic presenile and senile dementia]. (1974) (0)
79 Biochemical heterogeneity in schizophrenia due to gender: A multivariate study of post-mortem brain biochemistry (1997) (0)
Title Page / Table of Contents, Vol. 28, Supplement 2, 1982 (1982) (0)
[Psychotherapy of psychoses--research in accordance with the ethical norms?]. (1990) (0)
Dementia disorders and aging (1988) (0)
[Clinical experiences with marsilid in the treatment of psychiatric patients]. (1959) (0)
Author response for "Open‐label study with the monoamine stabilizer (‐)‐OSU6162 in myalgic encephalomyelitis/chronic fatigue syndrome" (2020) (0)
Preface (1999) (0)
Lågtidsbehandling med neuroleptika (1976) (0)
Round‐table discussion (1981) (0)
[Decentralization the psychiatric care]. (1974) (0)
[Psychiatric specialist in the general practitioner's office?]. (1974) (0)
[At last an interest in geriatric dementia arises]. (1978) (0)
Proteolytic Activity is Increased in Lymphocytes from Patients with Alzheimer’s Disease (1997) (0)
Delirium in the elderly: epidemiological, pathogenetic, diagnostic and treatment aspects. Proceedings of the 3rd Symposium on Aging and Aging Disorders. Stockholm, Sweden, September 3-4, 1998. (1999) (0)
Biochemistry of the human brain in old age and dementia. (1987) (0)
Is Alzheimer's a homogeneous disease, Are plaques critical and Does the blood brain barrier really contribute? (1986) (0)
Serotoninergic approach: why serotoninergic substitution? Clinical experience with 5-HT uptake inhibitors (1991) (0)
[Experiments with Librium among a psychiatric clientele]. (1961) (0)
[Human therapy research must be approved by the ethical committee]. (1990) (0)
Serum glutamyltransferase during long-term treatment for ethanol abuse in relation to clinical status and biochemical markers (1980) (0)
[Clinical research with imipramine-N-oxide in mental depression]. (1968) (0)
Drug preparation and methods for treatment and prevention of chronic fatigue syndrome and fybromyalgie (1997) (0)
Amines, Aging and Affective Disorders1 (1981) (0)
[The administrative court of appeal made the Gillberg issue go wrong. Unclear allocation of responsibility between the ethics committee and the court]. (2005) (0)
[Monamines (1): post-mortem studies of monoamines and related enzymes in the human brain]. (1978) (0)
staphylococcal bacteria-irritable use for the treatment of kolon (2000) (0)
Annals of psychiatry basic and clinical neurosciences: Alzheimer's disease by R. Cacabelos and B. Winblad (eds.), Prous Science Publishers, Barcelona, 1994 (1996) (0)
Antidepressants in Neurological Disorders (1997) (0)
Gangliosides and myelin lipids in senile and presenile dementia (1985) (0)
[Clinical research with flupenthixol-depot treatment of chronic schizophrenic psychoses]. (1970) (0)
[Psychotherapy of psychoses--research according to valid ethical standards?]. (1990) (0)
[The emotional capacity of humans--unexplored and unused possibility]. (1992) (0)
[Evaluation of pharmacological treatment of psychosis]. (1973) (0)
[Monoamines (2): reduced monoamine levels in senile dementia. Relation between monoamine levels, age and grade of dementia]. (1978) (0)
[Monoamines (3): postmortem studies on the human brain in a suicide group]. (1978) (0)
Conclusions (1971) (0)
[A study of psychiatric long term care. Mentally ill elderly persons with behavioral disorders need not only nursing home care but also other forms of care and housing]. (1991) (0)
Aging and the Brain (1989) (0)
1460 – CSF AMINE METABOLITES IN VARIOUS NEUROLOGICAL AND PSYCHIATRIC DISEASES (1977) (0)
Alzheimer's disease. (1986) (0)
Treatment of depression and other emotional disturbances in the elderly (2001) (0)
O-27-8 Cell membrane components in the thalamus of schizophrenic brains (1996) (0)
no evidence for XMRV infection in Sweden (2012) (0)
Contents Vol. 12, 2001 (2001) (0)
[Haloperidol and methylperidol]. (1968) (0)
severity of delirium in the elderly. Confusional State Evaluation (CSE): an instrument for measuring (2011) (0)
The Liege physiognomy of neuroleptics, with special reference to thioxanthenes. (1974) (0)
A pharmaceutical composition and method for the treatment and prevention of fibromyalgia and chronic fatigue (1997) (0)
NEUROTRANSMITTERS AND RELATED ENZYMES IN NORMAL AGING AND SENILE DEMENTIA (1980) (0)
Contents Vol. 1, 1990 (1990) (0)
[Aging and dementia-epidemiology, diagnosis and organization of care]. (1980) (0)

This paper list is powered by the following services:

Carl‐gerhard Gottfries's Academic­Influence.com Rankings

Why Is Carl‐gerhard Gottfries Influential?

Carl‐gerhard Gottfries's Published Works

Published Works

Carl‐gerhard Gottfries's AcademicInfluence.com Rankings